- Home
- MSI vs ALNY Comparison
MSI vs ALNY Comparison
Compare MSI & ALNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSI
- ALNY
- Stock Information
- Founded
- MSI 1928
- ALNY 2002
- Country
- MSI United States
- ALNY United States
- Employees
- MSI N/A
- ALNY N/A
- Industry
- MSI Radio And Television Broadcasting And Communications Equipment
- ALNY Biotechnology: Pharmaceutical Preparations
- Sector
- MSI Technology
- ALNY Health Care
- Exchange
- MSI Nasdaq
- ALNY Nasdaq
- Market Cap
- MSI 72.8B
- ALNY 59.1B
- IPO Year
- MSI N/A
- ALNY 2004
- Fundamental
- Price
- MSI $439.89
- ALNY $462.31
- Analyst Decision
- MSI Buy
- ALNY Strong Buy
- Analyst Count
- MSI 9
- ALNY 27
- Target Price
- MSI $513.78
- ALNY $466.46
- AVG Volume (30 Days)
- MSI 666.9K
- ALNY 1.0M
- Earning Date
- MSI 10-30-2025
- ALNY 10-30-2025
- Dividend Yield
- MSI 0.98%
- ALNY N/A
- EPS Growth
- MSI 45.12
- ALNY N/A
- EPS
- MSI 12.42
- ALNY N/A
- Revenue
- MSI $11,093,000,000.00
- ALNY $2,461,963,000.00
- Revenue This Year
- MSI $8.65
- ALNY $60.04
- Revenue Next Year
- MSI $7.50
- ALNY $40.69
- P/E Ratio
- MSI $35.81
- ALNY N/A
- Revenue Growth
- MSI 6.45
- ALNY 5.01
- 52 Week Low
- MSI $388.90
- ALNY $205.87
- 52 Week High
- MSI $507.82
- ALNY $495.55
- Technical
- Relative Strength Index (RSI)
- MSI 38.11
- ALNY 50.88
- Support Level
- MSI $434.47
- ALNY $456.90
- Resistance Level
- MSI $452.25
- ALNY $495.55
- Average True Range (ATR)
- MSI 7.29
- ALNY 15.46
- MACD
- MSI -1.02
- ALNY -1.65
- Stochastic Oscillator
- MSI 17.50
- ALNY 28.66
About MSI Motorola Solutions Inc.
Motorola Solutions is a leading provider of communications and analytics, primarily serving public safety departments as well as schools, hospitals, and businesses. The bulk of the firm's revenue comes from sales of land mobile radios and radio network infrastructure, but the firm also sells surveillance equipment and dispatch software. Most of Motorola's revenue comes from government agencies, while roughly 25% comes from schools and private businesses. Motorola has customers in over 100 countries and in every state in the United States.
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.